What is the market cap of Nephro Care India Limited?

As of 29/05/2026, the market cap of Nephro Care India Limited stands at ₹125.70 Cr.

What is the PE and PB ratio of Nephro Care India Limited?

The PE and PB ratios of Nephro Care India Limited is 34.5 ratio and 32.44 ratio as of 29/05/2026.

What is the 52 week high and low of Nephro Care India Limited?

The 52 week high and low of Nephro Care India Limited is ₹183 and ₹50.05 as of 29/05/2026.

How can I buy Nephro Care India Limited share?

You can easily buy Nephro Care India Limited shares on the Bajaj Broking platform by opening a Demat account and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.

What determines a company’s share price?

A company’s share price is determined by supply and demand dynamics in the stock market. Factors influencing it include the company’s financial performance, earnings growth, revenue, and profitability, as well as broader economic conditions, market sentiment, and investor perception. Other determinants include sector trends, government policies, interest rates, and global events. Positive news or growth prospects can drive demand and raise the share price, while negative developments can push it lower. Analysts’ recommendations, institutional buying or selling, and technical factors such as trading volume also influence price movements. Ultimately, the share price reflects the market’s collective view of a company’s current and future value.

What is the “last sale,” “bid,” and “ask” price of Nephro Care India Limited?

The “last sale” is the most recent price at which a stock, like Nephro Care India Limited , was traded. The “bid” price represents the highest price buyers are willing to pay, while the “ask” price is the lowest price sellers are ready to accept. The difference between the bid and ask is known as the spread. Monitoring these prices helps investors understand market sentiment and liquidity. For example, a narrow spread indicates high liquidity and active trading, while a wide spread may suggest lower activity or higher volatility. These metrics are crucial for executing timely buy or sell orders in the stock market.

How to read share price charts for Nephro Care India Limited?

Share price charts display the historical price movement of Nephro Care India Limited , helping investors analyse trends, patterns, and potential entry or exit points. Charts typically show candlestick patterns, line graphs, or bar charts, representing open, high, low, and close prices. Key indicators include moving averages, support and resistance levels, and trading volume. Candlestick patterns can reveal bullish or bearish trends, while volume confirms the strength of price movements. Investors can use charts for technical analysis to assess momentum, predict short-term fluctuations, or complement fundamental analysis for long-term decisions. Understanding trends over daily, weekly, or monthly periods helps in making informed trading and investment choices.

What is volatility, and how does it affect share price movement for Nephro Care India Limited?

Volatility measures the degree of price fluctuations of a stock over time. High volatility indicates that Nephro Care India Limited share price can experience large swings in short periods, while low volatility suggests stable prices. Factors causing volatility include market sentiment, earnings announcements, global events, economic indicators, and industry news. High volatility can create opportunities for traders to profit from rapid price changes but also increases risk for long-term investors. Understanding volatility helps investors manage risk, set stop-loss limits, and determine the appropriate investment horizon based on their risk tolerance.

NEPHRO CARE INDIA LIMITED

NEPHROCARE

Small Cap | Healthcare

₹76.25

-4 (-4.98%)

‌

Stock price as on 29 May 2026 at 15:24 PM

Nephro care india limited share price update

As of the latest trading session, Nephro Care India Limited share price is currently at ₹76.25, which is down by ₹-4 from its previous closing. Today ...

Nephro Care India Limited stock performance

Today’s low

₹76.25

Today’s high

₹77

₹76.25

52 week low

₹50.05

52 week high

₹183

₹76.25

Open

₹77.00

Previous close

₹80.25

Share volume

16,800

Total traded value (Lakh)

₹12.81

Upper circuit

₹84.25

Lower circuit

₹76.25

Nephro Care India Limited fundamentals

Market cap (Cr)

₹125.70

P/E ratio (TTM)

34.5

Book value per share

₹32.44

Beta

1.2

Return on equity

8.38%

Earnings per share (TTM)

₹1.74

Dividend yield

Net profit/quarter (Cr)

₹1.00

Nephro Care India Limited financials

(Values in Cr)

Revenue

Net income

Particulars	Mar 26 (₹ value in crores)
Revenue	₹26.75
Operating expense	₹26.27
Net income	₹1.00
Net profit margin	3.73%
Earning per share	₹0.61
EBITDA	₹2.85
Effective tax rate	22.3%

Particulars	Dec 25 (₹ value in crores)
Revenue	₹22.66
Operating expense	₹22.18
Net income	₹0.42
Net profit margin	1.85%
Earning per share	₹0.26
EBITDA	₹1.99
Effective tax rate	25%

Particulars	Mar 24 (₹ value in crores)
Revenue	₹7.48
Operating expense	-
Net income	₹1.01
Net profit margin	13.5%
Earning per share	₹0.85
EBITDA	-
Effective tax rate	-

Particulars	Dec 23 (₹ value in crores)
Revenue	₹6.65
Operating expense	-
Net income	-₹0.25
Net profit margin	-3.75%
Earning per share	-
EBITDA	-
Effective tax rate	-

Particulars	Mar 26 (₹ value in crores)
Revenue	₹88.73
Operating expense	₹85.64
Net income	₹3.37
Net profit margin	3.79%
Earning per share	₹2.04
EBITDA	₹9.87
Effective tax rate	27.37%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹46.03
Operating expense	₹42.73
Net income	₹3.64
Net profit margin	7.9%
Earning per share	₹2.38
EBITDA	₹7.40
Effective tax rate	24.63%

Particulars	Mar 24 (₹ value in crores)
Revenue	₹27.23
Operating expense	₹21.38
Net income	₹4.41
Net profit margin	16.19%
Earning per share	₹3.80
EBITDA	₹6.84
Effective tax rate	27.65%

Particulars	Mar 23 (₹ value in crores)
Revenue	₹17.09
Operating expense	₹14.52
Net income	₹2.37
Net profit margin	13.86%
Earning per share	₹38.85
EBITDA	₹3.42
Effective tax rate	7.75%

Particulars	Mar 22 (₹ value in crores)
Revenue	₹3.42
Operating expense	₹3.43
Net income	-₹0.01
Net profit margin	-0.29%
Earning per share	-₹0.20
EBITDA	₹0.13
Effective tax rate	-

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹32.44
Return on Equity (ROE)	8.38%
Return on Capital Employed (ROCE)	11.18%
Total debt to equity ratio	-
EBITDA margin	13.7%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹12.62
Return on Equity (ROE)	50.26%
Return on Capital Employed (ROCE)	61.86%
Total debt to equity ratio	0.14
EBITDA margin	24.47%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹50.57
Return on Equity (ROE)	156.44%
Return on Capital Employed (ROCE)	65.51%
Total debt to equity ratio	1.65
EBITDA margin	18.84%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹9.90
Return on Equity (ROE)	-153.85%
Return on Capital Employed (ROCE)	1.59%
Total debt to equity ratio	6.22
EBITDA margin	4.09%

Particulars (annual)	Mar 21 (₹ value in crores)
Book value per share	₹15.00
Return on Equity (ROE)	450%
Return on Capital Employed (ROCE)	20.83%
Total debt to equity ratio	34.57
EBITDA margin	8.79%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹4.65
Total assets	₹68.28
Total liabilities	₹68.28
Total equity	₹53.48
Shares outstanding	₹1.64
Price to book ratio	₹3.92
Return on assets (%)	5.32%
Return on capital	6.8%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹1.29
Total assets	₹20.96
Total liabilities	₹20.96
Total equity	₹15.02
Shares outstanding	₹1.19
Price to book ratio	-
Return on assets (%)	21.03%
Return on capital	29.36%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹2.31
Total assets	₹8.25
Total liabilities	₹8.25
Total equity	₹2.52
Shares outstanding	₹0.05
Price to book ratio	-
Return on assets (%)	28.72%
Return on capital	47.35%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹0.60
Total assets	₹4.62
Total liabilities	₹4.62
Total equity	₹0.49
Shares outstanding	₹0.05
Price to book ratio	-
Return on assets (%)	-0.21%
Return on capital	-0.32%

Particulars	Mar 21 (₹ value in crores)
Cash and short term investments	₹0.48
Total assets	₹1.28
Total liabilities	₹1.28
Total equity	₹0.21
Shares outstanding	-
Price to book ratio	-
Return on assets (%)	10.53%
Return on capital	14.85%

Particulars	Mar 25 (₹ value in crores)
Net income	₹4.82
Cash from operations	₹9.06
Cash from investing	-₹39.55
Cash from financing	₹35.10
Net change in cash	₹3.36
Free cash flow	₹38.27

Particulars	Mar 24 (₹ value in crores)
Net income	₹6.22
Cash from operations	₹3.20
Cash from investing	-₹7.53
Cash from financing	₹5.60
Net change in cash	-₹1.02
Free cash flow	₹5.63

Particulars	Mar 23 (₹ value in crores)
Net income	₹2.57
Cash from operations	₹4.16
Cash from investing	-₹2.33
Cash from financing	-₹0.08
Net change in cash	₹1.70
Free cash flow	₹4.66

Particulars	Mar 22 (₹ value in crores)
Net income	-
Cash from operations	₹0.68
Cash from investing	-₹2.81
Cash from financing	₹2.32
Net change in cash	₹0.12
Free cash flow	₹2.13

Particulars	Mar 21 (₹ value in crores)
Net income	₹0.11
Cash from operations	₹0.19
Cash from investing	-₹0.06
Cash from financing	₹0.27
Net change in cash	₹0.44
Free cash flow	₹0.26

Company name	Price	P/E	P/B	Market cap	52 week low/high
APOLLO HOSPITALS ENTERPRISE LT	₹8,177.95	60.11	12.41	₹1,17,586.37	₹6,680.00 / ₹8,490.30
FORTIS MALAR HOSPITALS LIMITED	₹53.98	24.43	2.94	₹101.17	₹40.75 / ₹77.00
SHREE PACETRONIX LTD.	₹142.40	16.99	2.99	₹53.40	₹66.10 / ₹283.15
TRANSGENE BIOTEK LTD.	₹3.15	0	2.59	₹23.87	₹1.83 / ₹5.26

Company name	Price	P/E	P/B	Market cap	52 week low/high
APOLLO HOSPITALS ENTERPRISE LT	₹8,177.95	60.11	12.41	₹1,17,586.37	₹6,680.00 / ₹8,490.30
FORTIS MALAR HOSPITALS LIMITED	₹53.98	24.43	2.94	₹101.17	₹40.75 / ₹77.00
SHREE PACETRONIX LTD.	₹142.40	16.99	2.99	₹53.40	₹66.10 / ₹283.15
TRANSGENE BIOTEK LTD.	₹3.15	0	2.59	₹23.87	₹1.83 / ₹5.26

Nephro Care India Limited technical summary

₹76.25

-4.98 ▼

Bearish

Bullish

5 Day79.3

10 Day80.2

12 Day80.4

20 Day80.7

26 Day80.5

50 Day81

100 Day88.4

200 Day107.6

Investment Returns

Over 1 Month13.93%▼

Over 3 Months4.38%▲

Over 6 Months43.03%▼

Over 1 Year43.56%▼

Nephro Care India Limited Shareholding pattern

Public

36.26%

Promoter holdings

61.71%

FII

0.72%

DII

1.29%

Promoter shares

Promoter shares	Share	Category
Pratim Sengupta	1,00,54,000 (60.98%)	Shareholding of Promoter and Promoter Group
Shila Sengupta	48,000 (0.29%)	Shareholding of Promoter and Promoter Group
Pradyot Kumar Sengupta	48,000 (0.29%)	Shareholding of Promoter and Promoter Group
Prasenjit Sengupta	24,000 (0.15%)	Shareholding of Promoter and Promoter Group

About NEPHRO CARE INDIA LIMITED

Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal. Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients. The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. The main business of the company is to provide comprehensive 360 Degree healthcare servicing to the patients with kidney related services, The Company operate only in non -invasive service, their operations have been supported by a pool of expert Doctors, experienced and well-trained paramedical professionals and a skilled management team. The entire team is further supported by sufficient clinical and investigative infrastructure. The Company in 2021, started flagship Salt Lake, Kolkata clinic; it started two satellite clinics operations at Chandannagar, in West Bengal in 2023, by taking up a Dialysis unit with e-Age Healthcare. The high cost of dialysis care has led to financial hardship for practically all families with such patients. Apart from this, the clinics have been equipped with technologically advanced equipment and diagnostic instruments. At present, Nephro Care offers the services at their clinics following Inhouse Dialysis Unit; Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology; NABL accredited inhouse Pathology; Inhouse Pharmacy; Advance diagnostic facilities; Renal Nutrition department; Home Care; Mukti (Lifestyle Support Program) and Home Dialysis. Besides, it has in house diagnostic tools including UGS, ECHO, ECG, X Ray, PFT, NCB, Fibroscan, Sudoscan, Fundoscopy, BCM, Polysomnography, Holter monitoring which ensure complete screening and accurate diagnosis. The Company launched its IPO comprising a fresh issue of 45,84,000 equity shares of Rs 10 per equity shares by raising Rs 41.25 crores on July 02, 2024. On 1st July, 2024, the company inaugurated a state of the art renal care clinic in Alipurduar, West Bengal. The Company opened its Vivacity Multispecialty Hospital in Madhyamgram, Kolkata in 2025. It launched a Cardiothoracic & Vascular Surgery (CTVS) unit to deliver advanced cardiac and vascular care to residents of North 24 Parganas district. On 1st March, 2025, the company has inaugurated its new unit in the heart of Kolkata in Shyambazar.

Parent Organisation

Indian Private

NSE Symbol

NEPHROCARE

Founded

2014

NEPHRO CARE INDIA LIMITED CORPORATE ACTION

No data available.

View more stocks

apollo hospitals enterprise lt

₹8,176.5

▼ 1.16%

max healthcare institute limit

₹965.1

▼ 2.85%

fortis healthcare ltd

₹928.45

▼ 3.37%

narayana hrudayalaya ltd.

₹1,894

▼ 1.36%

aster dm healthcare limited

₹728.35

▼ 1.74%

global health limited

₹1,189

▼ 1.55%

krishna inst of med sci l

₹758.85

▼ 3.26%

What’s trending

All stocks

QLINE

Q-LINE BIOTECH LIMITED

474.6

+131.6 (+38.37%)

SUPRIYA

SUPRIYA LIFESCIENCE LTD

968.7

+161.45 (+20%)

VIVAA

VIVAA TRADECOM LIMITED

44.4

+7.4 (+20%)

DEEM

DEEM ROLL TECH LIMITED

47.4

+7.9 (+20%)

View all

Top gainers

TECHM

TECH MAHINDRA LIMITED

HCL TECHNOLOGIES LTD

WIPRO LTD

LARSEN & TOUBRO LTD.

Top losers

INDIGO

INTERGLOBE AVIATION LTD

EICHER MOTORS LTD

BAJAJ AUTO LIMITED

POWER GRID CORP. LTD.

290.55

-9.60 (-3.20%)

View all

Frequently asked questions

 As of 29/05/2026, at 15:24 PM, the Nephro Care India Limited share price stands at ₹76.25.

Related tags

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

NEPHRO CARE INDIA LIMITED

Nephro care india limited share price update

Nephro Care India Limited stock performance

₹76.25

₹77

₹50.05

₹183

Nephro Care India Limited fundamentals

Nephro Care India Limited financials

Particulars

Mar 26 (₹ value in crores)

Revenue

₹26.75

Operating expense

₹26.27

Net income

₹1.00

Net profit margin

3.73%

Earning per share

₹0.61

EBITDA

₹2.85

Effective tax rate

22.3%

Particulars

Dec 25 (₹ value in crores)

Revenue

₹22.66

Operating expense

₹22.18

Net income

₹0.42

Net profit margin

1.85%

Earning per share

₹0.26

EBITDA

₹1.99

Effective tax rate

25%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹7.48

Operating expense

-

Net income

₹1.01

Net profit margin

13.5%

Earning per share

₹0.85

EBITDA

-

Effective tax rate

-

Particulars

Dec 23 (₹ value in crores)

Revenue

₹6.65

Operating expense

-

Net income

-₹0.25

Net profit margin

-3.75%

Earning per share

-

EBITDA

-

Effective tax rate

-

Particulars

Mar 26 (₹ value in crores)

Revenue

₹88.73

Operating expense

₹85.64

Net income